Tislelizumab: an effective treatment option for early-stage triple-negative breast cancer
@article{TBCR80672,
author = {Zhigang Yu},
title = {Tislelizumab: an effective treatment option for early-stage triple-negative breast cancer},
journal = {Translational Breast Cancer Research},
volume = {5},
number = {0},
year = {2023},
keywords = {},
abstract = {},
issn = {2218-6778}, url = {https://tbcr.amegroups.org/article/view/80672}
}